MentisCare In the news

A multi-year Sponsored Research Agreement with Emory’s School of Medicine to build a transformer-based EEG foundation model that works reliably across clinical and wearable settings, addressing a persistent barrier to real-world epilepsy care. TORONTO, ON – March 16, 2026 – Mentis Care, an AI-driven neuromonitoring company, today announced a two-year research collaboration with Emory University to develop channel-agnostic AI models

SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven platform commercialization. SEOUL, South Korea, Oct. 20, 2025 — SK Biopharmaceuticals, Co., Ltd., a biotech company focusing on research, development, and commercialization of treatments for disorders of the central nervous system (CNS) and oncology worldwide, today announced the establishment of Mentis Care, Inc., a joint